Doğu Cihan Yıldırım

Dr. Doğu Cihan Yıldırım

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2025 in Brain and Spine
Verified
Journal Article
Open access
ADAli Haluk DÜZKALIR
Ali Haluk DÜZKALIR
DYDoğu Cihan Yıldırım
Doğu Cihan Yıldırım
TATimoteo Almeida
Timoteo Almeida
ANAjay Niranjan
Ajay Niranjan
LLL. Dade Lunsford
L. Dade Lunsford
Selçuk PekerSelçuk Peker
Selçuk Peker
Intracranial Langerhans cell histiocytosis (iLCH) is rare and optimal local therapy remains undefined. Stereotactic radiosurgery (SRS) has emerged as a focused alternative to surgery or conventional radiotherapy for selected lesions. To report long-term outcomes of Gamma Knife radiosurgery (GKRS) for iLCH across multiple institutions. We retrospectively reviewed four patients (eight lesions) treated with GKRS between 2003 and 2015 at four institutions affiliated with the International Radiosurgery Research Foundation (IRRF). Inclusion required histopathologic LCH, single- or hypofractionated SRS to brain lesions, and ≥6 months radiological follow-up. Responses were assessed volumetrically (regression ≥20 %; progression ≥20 %). SRS-related toxicity was evaluated using the Radiation Therapy Oncology Group criteria for CNS toxicity. The median age at GKRS was 27 years. Four patients were treated, three with single lesions and one with five lesions across three sessions; most affected the cerebellum (n = 5). Median dose was 13 Gy (range: 8–14 Gy) with a median tumor volume of 2.7 cc. All lesions regressed with no local failures. Side effects were minimal, limited to one case of grade 2 edema. No necrosis or major morbidity occurred. GKRS provided durable radiographic regression and local control of iLCH with minimal toxicity, using a median prescription dose of 13 Gy. This approach represents a valuable, minimally invasive option for localized iLCH, while endocrine dysfunctions typically persist. Further prospective and collaborative investigations are essential to standardize dosing, evaluate combination approaches with systemic regimens, and refine guidelines for patient selection.

14 March 2026 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
ADAli Haluk DÜZKALIR
Ali Haluk DÜZKALIR
HDHanife Gulden Duzkalir
Hanife Gulden Duzkalir
DYDoğu Cihan Yıldırım
Doğu Cihan Yıldırım
MAMehmet Orbay Orbay Askeroğlu
Mehmet Orbay Orbay Askeroğlu
Selçuk PekerSelçuk Peker
Selçuk Peker

14 April 2026 in Journal of Neuro-Oncology
Verified
Journal Article
Open access
PDF file
ADAli Haluk DÜZKALIR
Ali Haluk DÜZKALIR
DYDoğu Cihan Yıldırım
Doğu Cihan Yıldırım
MAMehmet Orbay Orbay Askeroğlu
Mehmet Orbay Orbay Askeroğlu
Selçuk PekerSelçuk Peker
Selçuk Peker
Purpose: To evaluate the long-term efficacy and safety of single-fraction Gamma Knife radiosurgery (GKRS) for pineal region meningiomas (PMs) and to clarify its role as both a primary and adjuvant treatment strategy for this anatomically challenging tumor location. Methods: This single-center retrospective cohort study included 44 consecutive adults with PMs treated with single-fraction GKRS. Diagnosis was established histopathologically after prior surgery or by predefined MRI criteria with consensus neuroradiological review. Tumor response was assessed volumetrically on serial contrast-enhanced MRI, with regression, stability, and progression defined as ≥ 20% decrease, < 20% change, and ≥ 20% increase in tumor volume, respectively. Local control (LC), progression-free survival (PFS), overall survival (OS), adverse radiation effects (AREs), and Karnofsky Performance Scale (KPS) outcomes were analyzed. Results: Median clinical and radiological follow-up were 90 and 88 months, respectively. At last radiological follow-up, LC was achieved in 42 of 44 patients (95.5%), including regression in 13 (29.5%) and stability in 29 (65.9%). Kaplan-Meier LC rates were 100% at 2 years, 97.1% at 5 years, and 86.3% at 10 years. PFS rates were 100%, 94.1%, and 72.6% at 2, 5, and 10 years, respectively. AREs occurred in 3 patients (6.8%), all without permanent sequelae. KPS remained stable or improved in all patients. Conclusion: Single-fraction GKRS provides durable tumor control with low toxicity and preserved neurological function in PMs, supporting its use as a primary treatment strategy in selected patients. Preliminary adjuvant results are encouraging but require validation in larger cohorts.

3 November 2026 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
ADAli Haluk DÜZKALIR
Ali Haluk DÜZKALIR
DYDoğu Cihan Yıldırım
Doğu Cihan Yıldırım
MAMehmet Orbay Orbay Askeroğlu
Mehmet Orbay Orbay Askeroğlu
Selçuk PekerSelçuk Peker
Selçuk Peker

2 September 2026 in Neurochirurgie
Verified
Journal Article
Closed access
ADAli Haluk DÜZKALIR
Ali Haluk DÜZKALIR
HDHanife Gulden Duzkalir
Hanife Gulden Duzkalir
DYDoğu Cihan Yıldırım
Doğu Cihan Yıldırım
MAMehmet Orbay Orbay Askeroğlu
Mehmet Orbay Orbay Askeroğlu
Selçuk PekerSelçuk Peker
Selçuk Peker

2 December 2025 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
ADAli Haluk DÜZKALIR
Ali Haluk DÜZKALIR
DYDoğu Cihan Yıldırım
Doğu Cihan Yıldırım
MTManjul Tripathi
Manjul Tripathi
DMDavid Mathieu
David Mathieu
NMNuria M. Moreno
Nuria M. Moreno
Selçuk PekerSelçuk Peker
Selçuk Peker